Kingworld Medicines Group Bilan de santé
Santé financière contrôle des critères 5/6
Kingworld Medicines Group possède un total de capitaux propres de CN¥756.7M et une dette totale de CN¥375.5M, ce qui porte son ratio d'endettement à 49.6%. Son actif total et son passif total sont CN¥1.5B et de CN¥754.9M. L'EBIT de Kingworld Medicines Group est CN¥76.7M ce qui fait que son ratio de couverture des intérêts -409.9. Elle dispose de liquidités et de placements à court terme de CN¥302.1M.
Informations clés
49.6%
Ratio d'endettement
CN¥375.46m
Dette
| Ratio de couverture des intérêts | -409.9x |
| Argent liquide | CN¥302.10m |
| Fonds propres | CN¥756.70m |
| Total du passif | CN¥754.92m |
| Total des actifs | CN¥1.51b |
Mises à jour récentes de la santé financière
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05Recent updates
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 1110 ( CN¥662.0M ) dépassent ses passifs à court terme ( CN¥574.7M ).
Passif à long terme: Les actifs à court terme de 1110 ( CN¥662.0M ) dépassent ses passifs à long terme ( CN¥180.2M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de 1110 ( 9.7% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de 1110 est passé de 40.5% à 49.6% au cours des 5 dernières années.
Couverture de la dette: La dette de 1110 est bien couverte par le flux de trésorerie opérationnel ( 31.1% ).
Couverture des intérêts: 1110 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.